Merck in New Defective Drug Scandal ~ OPOLAW Injury Blog

Thursday, January 29, 2009

Merck in New Defective Drug Scandal

Pharmaceutical company Merck is facing fresh controversy after it was discovered that their osteoporosis drug Fosamax may be linked to Osteonecrosis of the Jaw (ONJ). ONJ, also known as "Dead Jaw", is an extremely serious condition where the temporary or permanent loss of blood to bone tissue leads to death of the tissue and eventually causes the bone to collapse. Merck had ignored a request by the FDA in 2004 to add an appropriate warning label to Fosamax out of fear it would cause a loss in profits. Hundreds of Fosamax users are suffering from ONJ as a result of Merck's negligence. Merck are also facing a multitude of lawsuits regarding their anti-inflammatory drug Vioxx, which was pulled from the market in 2004 after research showed the drug doubled the risk of heart attack and stroke if used for over 18 months.

No comments:

Post a Comment